Pfanstiel Steven 4

What Happened
Steven Pfanstiel, EVP, Chief Financial Officer and Treasurer of Neuronetics, was granted 25,000 restricted stock units (RSUs) on March 17, 2026. The Form 4 reports the acquisition as 25,000 shares at $0.00 (award), so no cash was exchanged. This is an equity award (compensation), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-17 (Form 4 filed 2026-03-18; filing appears timely).
• Transaction type/code: Award/Grant (A).
• Amount: 25,000 RSUs acquired at $0.00 per RSU (total reported acquisition value $0).
• Vesting: RSUs vest in three equal annual installments beginning March 17, 2027, subject to continuous service (footnote).
• Conversion: Each RSU represents a contingent right to receive one share of common stock upon vesting.
• Shares owned after transaction: Not specified in the filing.
• No 10b5-1 plan, tax-withholding, or sale reported in this filing.

Context
RSU awards are a common form of executive compensation and generally reflect future potential share delivery if vesting conditions are met; they do not represent immediate insider buying or selling. For investors, purchases and open-market sales often convey clearer near-term sentiment than routine compensation grants. Monitor future filings for vesting-related issuances or any subsequent open-market trades.